Skip to main content
Drug-TrendsPills-Conveyor-800x554-07172017.jpg
Drug-TrendsPills-Conveyor-800x554-07172017.jpg
Drug-TrendsPills-Conveyor-800x554-07172017.jpg

Drug Trends

Analyzing current drug utilization and spending trends in workers’ comp

2016 Drug Trends Report

Coventry has been publishing annual drug trend analyses for nearly a decade. This year we’re delivering the report in a four part series which covers 2016 data for traditional, managed and unmanaged views. The 2016 Drug Trends Series is based on all calendar year transactions billed through Coventry’s PBM program and transactions from medical bill review to reflect the total pharmacy experience for our client base. 

Part 1: Evaluating the traditional retail and mail-order prescription view

In part one of our series we focus on an industry view that serves as a benchmark to traditional reporting including First Script’s historical reports.

Read the report

View the video introduction

Part 2: Addressing the Managed vs. Unmanaged Prescription View

In part two of our series we focus on the managed data which takes the traditional view (Retail + Mail Order), and adds prescriptions from our extended network and the unmanaged (out-of-network) prescriptions that are received and processed through medical bill review. 

Read the report

View the video introduction

Part 3: Assessing opioids and compounds

The third installment of our series is dedicated to two therapeutic classes, opioids and compounds, which are frequently discussed in workers’ comp and prescribed to treat pain associated with injuries.

Read the report

View the video introduction

 

Historical Drug Trends Reports

Get more information on historical workers' compensation drug trends by downloading past reports. 

View the 2015 Drug Trends Report

View the 2014 Drug Trends Report

You are now leaving the Aetna website
Continue

No message set yet.

You are now leaving the Aetna website
Coventry Connect is best viewed on the Coventry Connect App.If you prefer to view on the website click here.
Continue